Home » Topics » BioWorld Science

BioWorld Science
RSS

Emmaus Life Sciences screens first patient in phase I diverticulosis study

July 9, 2019

PTEN and CF

July 9, 2019

Botox for -- well, against -- mosquitoes

July 9, 2019

Novel rat model of multiple system atrophy unresponsive to L-dopa

July 9, 2019

DMC recommends continuation of phase Ib study of AVB-500 in ovarian cancer

July 8, 2019

Intra-Cellular Therapies reports topline phase III data on lumateperone in bipolar depression

July 8, 2019

FDA accepts Celyad's IND application for autologous NKG2D-based CAR-T cell therapy CYAD-02

July 8, 2019

4D pharma initiates phase I/II study of MRx-4DP0004 for asthma

July 8, 2019

[18F]MNI-1126 detects synaptic density loss in Alzheimer's disease and Parkinson's disease patients

July 8, 2019

TDP-43 screen identifies potential therapeutics for ALS and frontotemporal dementia

July 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...